VMI
AXSM icon

VHCP Management III’s Axsome Therapeutics AXSM Stock Holding History

VHCP Management III’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$160M Sell
1,547,994
-63,335
-4% -$2.56M 31.77% 1
2019
Q3 		$32.6M Hold
1,611,329
– – 20.13% 2
2019
Q2 		$41.5M Buy
1,611,329
+543,285
+51% +$10.9M 19.37% 2
2019
Q1 		$15.2M Buy
+1,068,044
New +$9.92M 8.86% 4

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VHCP Management III's AXSM Position: Q4 2019 in Review

VHCP Management III reduced its Axsome Therapeutics (AXSM) stake by 3.9% in Q4 2019, selling an estimated $2.56M and leaving 1,547,994 shares worth $160M. The position accounts for 31.77% of the portfolio, ranked #1.

VHCP Management III first reported a position in AXSM in Q1 2019 and has held it in 4 quarters since. 169 funds tracked by Wall St. Rank hold AXSM as of Q4 2019.

  • VHCP Management III held 1,547,994 shares of Axsome Therapeutics worth $160M as of Q4 2019.
  • VHCP Management III sold 63,335 Axsome Therapeutics shares in Q4 2019, an estimated $2.56M.
  • Axsome Therapeutics made up 31.77% of VHCP Management III's portfolio in Q4 2019, its #1 holding.
  • VHCP Management III first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 4 quarters since.
  • 169 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.